R
Richard M. Twyman
Researcher at University of Warwick
Publications - 193
Citations - 11486
Richard M. Twyman is an academic researcher from University of Warwick. The author has contributed to research in topics: Gene & Transgene. The author has an hindex of 56, co-authored 183 publications receiving 10322 citations. Previous affiliations of Richard M. Twyman include University of Giessen & Fraunhofer Society.
Papers
More filters
Journal ArticleDOI
Molecular farming in plants: host systems and expression technology.
TL;DR: Plants provide an inexpensive and convenient system for the large-scale production of valuable recombinant proteins and will only realize its huge potential if constraints are removed through rigorous and detailed science-based studies.
Journal ArticleDOI
Bacillus thuringiensis: a century of research, development and commercial applications.
TL;DR: Recent progress in the development of Bt technology and the countermeasures that have been introduced to prevent the evolution of resistant insect populations are reviewed.
Journal ArticleDOI
Plant-based production of biopharmaceuticals.
TL;DR: The first plant-derived recombinant pharmaceutical proteins are reaching the final stages of clinical evaluation, and many more are in the development pipeline, as shown by the continuing commercial development of novel plant-based expression platforms.
Journal ArticleDOI
Plant cell cultures for the production of recombinant proteins
TL;DR: Although no recombinant proteins have yet been produced commercially using plant cell cultures, there have been many proof-of-principle studies and several companies are investigating the commercial feasibility of such production systems.
Journal ArticleDOI
Molecular farming for new drugs and vaccines. Current perspectives on the production of pharmaceuticals in transgenic plants
Julian K.-C. Ma,Eugenia Barros,Ralph Bock,Paul Christou,Philip J. Dale,Philip J. Dix,Rainer Fischer,Rainer Fischer,Judith A. Irwin,Richard T. Mahoney,Mario Pezzotti,Stefan Schillberg,Penny Sparrow,Eva Stoger,Richard M. Twyman +14 more
TL;DR: Attention is now shifting from basic research towards commercial exploitation, and molecular farming is reaching the stage at which it could challenge established production technologies that use bacteria, yeast and cultured mammalian cells.